118 related articles for article (PubMed ID: 6087964)
1. Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B.
Bes JC; Salvayre R; Levade T; Caratero C; Planel H
Biol Cell; 1984; 50(3):299-302. PubMed ID: 6087964
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and ultrastructural findings in a lymphoid cell line from Niemann-Pick disease type A.
Levade T; Salvayre R; Bes JC; Maret A; Douste-Blazy L
Biol Cell; 1985; 55(1-2):143-6. PubMed ID: 3006848
[TBL] [Abstract][Full Text] [Related]
3. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and ultrastructural studies on an Epstein-Barr virus-transformed lymphoid cell line from a Niemann-Pick disease type C patient.
Levade T; Maret A; Salvayre R; Livni N; Rogalle P; Douste-Blazy L
Biochim Biophys Acta; 1986 Jul; 877(3):415-22. PubMed ID: 3015220
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
Levade T; Salvayre R; Lenoir G; Douste-Blazy L
Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
[TBL] [Abstract][Full Text] [Related]
6. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease types A and B.
Levade T; Salvayre R; Douste-Blazy L
Eur J Biochem; 1985 Jun; 149(2):405-9. PubMed ID: 2986976
[TBL] [Abstract][Full Text] [Related]
7. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
Graber D; Salvayre R; Levade T
J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
[TBL] [Abstract][Full Text] [Related]
8. Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.
Levade T; Salvayre R; Maret A; Douste-Blazy L
J Inherit Metab Dis; 1988; 11(2):151-7. PubMed ID: 3139926
[TBL] [Abstract][Full Text] [Related]
9. [Ultrastructural study of the liver in Niemann-Pick disease type C].
Chamlian A; Benkoël L; Payan MJ; Minko D; Xerri L; Choux R; Nouhou H
Ann Pathol; 1989; 9(2):132-6. PubMed ID: 2735974
[TBL] [Abstract][Full Text] [Related]
10. Specific enzymatic diagnosis and ultrastructural analysis of peripheral leukocytes in infantile form of Niemann-Pick sphingomyelinosis.
László A; Klujber L; Streitmann K; Barb E
Acta Paediatr Hung; 1990; 30(1):99-105. PubMed ID: 2156543
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and ultrastructural findings in Epstein-Barr virus-transformed lymphoid cell lines from type 1 Gaucher disease.
Maret A; Salvayre R; Livni N; Icart J; Vuillaume M; Douste-Blazy L
Biol Cell; 1987; 59(1):101-4. PubMed ID: 3038233
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical diagnostics of Niemann-Pick disease.
Maciejko D; Tylki-Szymańska A
Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathway for radiation-induced apoptosis in the lymphoblasts from neuronopathic (type A) and non-neuronopathic (type B) forms of Niemann-Pick disease.
Mikami T; Takahashi T; Ishida A; Minamiya Y; Ida H; Takada G
J Neurol Sci; 2002 Jul; 199(1-2):39-43. PubMed ID: 12084440
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase--deficient mouse model of Niemann-Pick disease.
Dhami R; He X; Gordon RE; Schuchman EH
Lab Invest; 2001 Jul; 81(7):987-99. PubMed ID: 11454988
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte enzymes in the detection of Niemann-Pick Carriers.
Hardy B; Hoffman J; Neri A
Biomed Pharmacother; 1982; 36(8-9):372-5. PubMed ID: 7182017
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction.
Yeyati PL; Agmon V; Fillat C; Dinur T; Dagan A; Desnick RJ; Gatt S; Schuchman EH
Hum Gene Ther; 1995 Aug; 6(8):975-83. PubMed ID: 7578419
[TBL] [Abstract][Full Text] [Related]
17. Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase.
Levade T; Gatt S; Maret A; Salvayre R
J Biol Chem; 1991 Jul; 266(21):13519-29. PubMed ID: 1649823
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
Klar R; Levade T; Gatt S
Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
[TBL] [Abstract][Full Text] [Related]
19. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
Poulos A; Ranieri E; Shankaran P; Callahan JW
Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
[TBL] [Abstract][Full Text] [Related]
20. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
Christomanou H
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
